New cancer drug tested in japanese patients – early results uncertain
Disease control
Terminated
This early-phase study tested the drug INCB086550 in 3 Japanese patients with advanced solid tumors that had stopped responding to other treatments. The main goal was to check safety and find the right dose. The study was terminated early, so we have limited information on how we…
Phase: PHASE1 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC